ATE388166T1 - Bioaktive peptide, die durch enzymatische hydrolyse aus den proteinen von eiweiss gewonnen werden - Google Patents

Bioaktive peptide, die durch enzymatische hydrolyse aus den proteinen von eiweiss gewonnen werden

Info

Publication number
ATE388166T1
ATE388166T1 AT04766983T AT04766983T ATE388166T1 AT E388166 T1 ATE388166 T1 AT E388166T1 AT 04766983 T AT04766983 T AT 04766983T AT 04766983 T AT04766983 T AT 04766983T AT E388166 T1 ATE388166 T1 AT E388166T1
Authority
AT
Austria
Prior art keywords
activity
treatment
peptides
bioactive peptides
proteins
Prior art date
Application number
AT04766983T
Other languages
English (en)
Inventor
Castro Marta Miguel
Fandino R Lopez-Alonso
Sanchez Maria I Recio
Gonzales Maria M Ramos
De Artinano A Aleixandre
Original Assignee
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion filed Critical Consejo Superior Investigacion
Application granted granted Critical
Publication of ATE388166T1 publication Critical patent/ATE388166T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8103—Exopeptidase (E.C. 3.4.11-19) inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/77—Ovalbumin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04766983T 2003-07-31 2004-07-23 Bioaktive peptide, die durch enzymatische hydrolyse aus den proteinen von eiweiss gewonnen werden ATE388166T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200301829A ES2253036B1 (es) 2003-07-31 2003-07-31 Peptidos bioactivos derivados de proteinas de la clara de huevo mediante hidrolisis enzimatica.

Publications (1)

Publication Number Publication Date
ATE388166T1 true ATE388166T1 (de) 2008-03-15

Family

ID=34112522

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04766983T ATE388166T1 (de) 2003-07-31 2004-07-23 Bioaktive peptide, die durch enzymatische hydrolyse aus den proteinen von eiweiss gewonnen werden

Country Status (8)

Country Link
US (1) US8227207B2 (de)
EP (1) EP1661913B1 (de)
JP (1) JP2007523045A (de)
AT (1) ATE388166T1 (de)
DE (1) DE602004012289T2 (de)
DK (1) DK1661913T3 (de)
ES (2) ES2253036B1 (de)
WO (1) WO2005012355A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006273850A (ja) * 2005-03-04 2006-10-12 Pharma Foods International Co Ltd 血中乳酸値上昇抑制組成物及びそれを含有する飲食品
ES2329316B1 (es) * 2005-05-23 2010-10-14 Consejo Superior Investig. Cientificas Obtencion y propiedades antihipertensivas de peptidos derivados de proteinas de clara de huevo.
JP2008156344A (ja) * 2006-11-27 2008-07-10 Q P Corp 生体内抗酸化材、生体内抗酸化用食品組成物及び生体内抗酸化用医薬品組成物、並びに肝機能障害抑制材、肝機能障害抑制用食品組成物及び肝機能障害抑制用医薬品組成物
US8946383B2 (en) 2008-08-01 2015-02-03 Naturex Obtaining cocoa extracts rich in bioactive peptides with ACE and PEP enzyme inhibitory activity
WO2010106437A1 (en) * 2009-03-20 2010-09-23 The Governors Of The University Of Alberta Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same
US8946164B2 (en) * 2010-04-07 2015-02-03 Kyoto University Bioactive peptide
EP2548458B1 (de) * 2011-07-22 2013-07-03 HPF Nutraceutics S.r.L. Lupinen-abgeleitete Verbindungen mit hypotonischer Wirkung und Verfahrensprozess zu ihrer Herstellung
KR101510178B1 (ko) 2013-05-27 2015-04-10 대한민국 항산화 펩타이드를 포함하는 조성물
WO2015082741A1 (es) * 2013-12-04 2015-06-11 Consejo Superior De Investigaciones Cientificas (Csic) Uso de productos bioactivos multifuncionales derivados de la hidrólisis enzimática de proteínas de clara de huevo para el tratamiento del síndrome metabólico
WO2016077457A1 (en) 2014-11-11 2016-05-19 Clara Foods Co. Methods and compositions for egg white protein production
CN104814439B (zh) * 2015-05-27 2017-09-29 吉林大学 一种蛋清小肽降压营养粉及制备方法
KR102056348B1 (ko) 2018-05-28 2019-12-16 주식회사 바이오프로후즈 난백 가수분해물의 제조방법 및 이의 용도
CN109485696B (zh) * 2018-11-06 2020-10-23 渤海大学 一种克服肠道降解的膜肽酶抑制肽
KR20220034848A (ko) 2019-07-11 2022-03-18 클라라 푸드즈 컴퍼니 단백질 조성물 및 이의 섭취 가능한 제품
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
CN110628856A (zh) * 2019-10-17 2019-12-31 武汉普诺金生物科技股份有限公司 一种降血压小分子肽及其制备方法和应用
CN112616925A (zh) * 2020-12-30 2021-04-09 光明乳业股份有限公司 一种双蛋白发酵乳及其制备方法
EP4046649A1 (de) 2021-02-22 2022-08-24 Bioseutica B.V. Ovotransferrine zur verwendung bei der behandlung von eisenmangelanämie
CN115477696A (zh) * 2022-09-27 2022-12-16 杭州佰倍优生物科技有限公司 一种改善乏力症状的白蛋白活性多肽粉及其制备方法
CN116444611B (zh) * 2022-11-30 2024-06-04 内蒙古伊利实业集团股份有限公司 乳源活性肽tdplfkg及其制备方法与应用
CN117264018B (zh) * 2023-09-26 2024-04-09 南京工业大学 一种鸽蛋清中功能肽的制备及其应用
CN118530340B (zh) * 2024-07-25 2024-10-29 青岛农业大学 一种具有抗氧化抗过敏功效的生物活性肽、组合物及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470970A (en) * 1991-02-28 1995-11-28 Dana-Farber Cancer Institute, Inc. Maspin, a serpin with tumor suppresing activity
JP3129523B2 (ja) * 1992-05-29 2001-01-31 日本合成化学工業株式会社 新規ペプチド及びその製造方法
GB9310472D0 (en) * 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
JPH09263597A (ja) * 1996-03-29 1997-10-07 Taiyo Kagaku Co Ltd 新規ペプチド
JP3770659B2 (ja) * 1996-07-23 2006-04-26 日本合成化学工業株式会社 新規ペプチド及びその製造方法
US5935968A (en) * 1997-03-17 1999-08-10 Merck & Co., Inc. Methods for treating polycystic ovary syndrome
JP2003504074A (ja) * 1999-07-08 2003-02-04 ストレスゲン バイオテクノロジーズ コーポレイション インビトロでのＴｈ１様応答の誘導
US6514941B1 (en) * 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides
EP1287159A4 (de) 2000-05-08 2005-02-09 Davisco Foods Int Inc Enzymatische behandlung von molkeproteinen zur produktion von blutdrucksenkenden peptiden, resultierende produkte daraus und behandlung von blutdruck in säugern
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases

Also Published As

Publication number Publication date
US8227207B2 (en) 2012-07-24
EP1661913A1 (de) 2006-05-31
US20060280804A1 (en) 2006-12-14
ES2253036A1 (es) 2006-05-16
WO2005012355A1 (es) 2005-02-10
JP2007523045A (ja) 2007-08-16
DE602004012289T2 (de) 2009-09-03
ES2253036B1 (es) 2007-07-16
DK1661913T3 (da) 2008-07-07
EP1661913B1 (de) 2008-03-05
ES2303090T3 (es) 2008-08-01
WO2005012355B1 (es) 2005-03-24
DE602004012289D1 (de) 2008-04-17

Similar Documents

Publication Publication Date Title
ATE388166T1 (de) Bioaktive peptide, die durch enzymatische hydrolyse aus den proteinen von eiweiss gewonnen werden
Akbarian et al. Bioactive peptides: Synthesis, sources, applications, and proposed mechanisms of action
Zou et al. Antihypertensive and antioxidant activities of enzymatic wheat bran protein hydrolysates
Kang et al. Antimicrobial and immunomodulatory properties and applications of marine-derived proteins and peptides
Adjonu et al. Screening of whey protein isolate hydrolysates for their dual functionality: Influence of heat pre-treatment and enzyme specificity
Hayes et al. Boarfish protein recovery using the pH-shift process and generation of protein hydrolysates with ACE-I and antihypertensive bioactivities in spontaneously hypertensive rats
Hajfathalian et al. Peptides: Production, bioactivity, functionality, and applications
Ibrahim et al. Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk
Agyei et al. Rethinking food-derived bioactive peptides for antimicrobial and immunomodulatory activities
Hernández-Ledesma et al. ACE-inhibitory and radical-scavenging activity of peptides derived from β-lactoglobulin f (19− 25). Interactions with ascorbic acid
Bah et al. Slaughterhouse blood: an emerging source of bioactive compounds
O'Sullivan et al. Bioactivity of bovine lung hydrolysates prepared using papain, pepsin, and Alcalase
García‐Moreno et al. Functional, bioactive and antigenicity properties of blue whiting protein hydrolysates: effect of enzymatic treatment and degree of hydrolysis
ATE478567T1 (de) Babynahrung mit hydrolisierten proteinen
Mora et al. Cardioprotective cryptides derived from fish and other food sources: Generation, application, and future markets
de Oliveira et al. Anti-hypertensive peptides derived from caseins: mechanism of physiological action, production bioprocesses, and challenges for food applications
Wang et al. Mechanisms and applications of milk-derived bioactive peptides in food for special medical purposes
WO2005082927A3 (en) Antihypertensive peptides
Bhat et al. Antihypertensive Peptides from Animal
Mustafa et al. Bioactive peptides and their natural sources
ATE477812T1 (de) Verwendung von tryptophanreichen peptiden aus molkenproteinhydrolysate zur behandlung von übergewicht und fettleibigkeit
WO2007134118A3 (en) Protein based composition and methods of using same
ATE401400T1 (de) Antiangiogene peptide zur behandlung oder vorbeugung von endometriose
Tsopmo et al. Enzymatic hydrolysis of oat flour protein isolates to enhance antioxidative properties
ATE493999T1 (de) Nahrungsmittel enthaltend dipeptide mit blutdrucksenkenden eigenschaften.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties